NEJM retracted the Tavneos ADVOCATE trial on June 29, 2026, after FDA found altered patient data. Patients should not stop Tavneos without a doctor — here’s what’s known.
The Clinical Trial That Supported Tavneos for ANCA Vasculitis Was Just Retracted
by | Jul 7, 2026 | Uncategorized | 0 comments
Recent Comments